Glutathione S‐transferase polymorphisms are associated with survival in anaplastic glioma patients

Glutathione S‐transferases (GSTs) are polymorphic enzymes that are responsible for glutathione conjugation of alkylators and scavenging of free radicals created by radiation. GST polymorphisms may result in altered or absent enzyme activity and have been associated with survival in patients with cancer. The authors of this report hypothesized that patients with anaplastic glioma (AG) who have GST genotypes that encode for lower activity enzymes will have longer survival than similar patients who have higher activity genotypes. The current study was performed to investigate the role of GST enzyme polymorphisms in predicting the survival of patients with AG.

[1]  R. Lothe,et al.  Cisplatin-induced long-term hearing impairment is associated with specific glutathione s-transferase genotypes in testicular cancer survivors. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  M. Loriot,et al.  Glutathione S-Transferase P1 Polymorphism (Ile105Val) Predicts Cumulative Neuropathy in Patients Receiving Oxaliplatin-Based Chemotherapy , 2006, Clinical Cancer Research.

[3]  Joe Y. Chang,et al.  Association between glutathione S‐transferase π polymorphisms and survival in patients with advanced nonsmall cell lung carcinoma , 2006, Cancer.

[4]  C. Wittmer,et al.  Polymorphisms of glutathione S-transferases (GST) and thymidylate synthase (TS) – novel predictors for response and survival in gastric cancer patients , 2005, British Journal of Cancer.

[5]  S. Holley,et al.  Polymorphisms in the glutathione S-transferase mu cluster are associated with tumour progression and patient outcome in colorectal cancer. , 2006, International journal of oncology.

[6]  T. Rebbeck,et al.  Drug-metabolizing enzyme polymorphisms predict clinical outcome in a node-positive breast cancer cohort. , 2005, Journal of Clinical Oncology.

[7]  Chien-Jen Chen,et al.  Association of GSTP1 Polymorphism and Survival for Esophageal Cancer , 2005, Clinical Cancer Research.

[8]  M. Voso,et al.  Glutathione S-transferase P1 Genotype and Prognosis in Hodgkin's Lymphoma , 2005, Clinical Cancer Research.

[9]  E. Cook,et al.  Pharmacogenetics of outcome in children with acute lymphoblastic leukemia. , 2004, Blood.

[10]  L. D.,et al.  Brain tumors , 2005, Psychiatric Quarterly.

[11]  I. M. Jones,et al.  XRCC1 and glutathione‐S‐transferase gene polymorphisms and susceptibility to radiotherapy‐related malignancies in survivors of Hodgkin disease , 2004, Cancer.

[12]  K. Hess,et al.  Glutathione S-Transferase Polymorphisms and Survival in Primary Malignant Glioma , 2004, Clinical Cancer Research.

[13]  T. Vaughan,et al.  Glutathione S-transferase M1, T1, and P1 polymorphisms and survival among lung cancer patients. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[14]  F. Ali-Osman,et al.  Allelic variants of the human glutathione S-transferase P1 gene confer differential cytoprotection against anticancer agents in Escherichia coli. , 2002, Pharmacogenetics.

[15]  L. Robison,et al.  Glutathione S-transferase genotypes, genetic susceptibility, and outcome of therapy in childhood acute lymphoblastic leukemia. , 2002, Blood.

[16]  S. Groshen,et al.  Association between glutathione S-transferase P1, T1, and M1 genetic polymorphism and survival of patients with metastatic colorectal cancer. , 2002, Journal of the National Cancer Institute.

[17]  T. Naoe,et al.  Prognostic significance of the null genotype of glutathione S-transferase-T1 in patients with acute myeloid leukemia: increased early death after chemotherapy , 2002, Leukemia.

[18]  P. Vineis,et al.  Metabolic gene polymorphism frequencies in control populations. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[19]  L. Hutchins,et al.  Polymorphisms in glutathione S-transferases (GSTM1 and GSTT1) and survival after treatment for breast cancer. , 2001, Cancer research.

[20]  J. Buckley,et al.  Glutathione S-transferase polymorphisms and outcome of chemotherapy in childhood acute myeloid leukemia. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  S. Srivastava,et al.  Activity of allelic variants of Pi class human glutathione S-transferase toward chlorambucil. , 2000, Biochemical and biophysical research communications.

[22]  P. Muti,et al.  Polymorphisms within glutathione S-transferase genes and initial response to glucocorticoids in childhood acute lymphoblastic leukaemia. , 2000, Pharmacogenetics.

[23]  W. Yung,et al.  Clinical trial end points in malignant glioma: need for effective trial design strategy. , 2000, Seminars in oncology.

[24]  M. Schrappe,et al.  Polymorphisms within glutathione S-transferase genes (GSTM1, GSTT1, GSTP1) and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia: a case-control study. , 2000, Blood.

[25]  M. Relling,et al.  Pharmacogenomics: translating functional genomics into rational therapeutics. , 1999, Science.

[26]  J. Cairncross,et al.  Which glioblastoma multiforme patient will become a long‐term survivor? A population‐based study , 1999, Annals of neurology.

[27]  S. Srivastava,et al.  Differential catalytic efficiency of allelic variants of human glutathione S-transferase Pi in catalyzing the glutathione conjugation of thiotepa. , 1999, Archives of biochemistry and biophysics.

[28]  C. Herzog,et al.  Differential protection against benzo[a]pyrene-7,8-dihydrodiol-9,10-epoxide-induced DNA damage in HepG2 cells stably transfected with allelic variants of pi class human glutathione S-transferase. , 1999, Cancer research.

[29]  D. Louis,et al.  Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. , 1998, Journal of the National Cancer Institute.

[30]  K. Hess,et al.  Prognostic significance of glutathione S-transferase pi expression and subcellular localization in human gliomas. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[31]  S. Srivastava,et al.  Activity of four allelic forms of glutathione S-transferase hGSTP1-1 for diol epoxides of polycyclic aromatic hydrocarbons. , 1997, Biochemical and biophysical research communications.

[32]  J. Buolamwini,et al.  Molecular Cloning, Characterization, and Expression in Escherichia coli of Full-length cDNAs of Three Human Glutathione S-Transferase Pi Gene Variants , 1997, The Journal of Biological Chemistry.

[33]  J. Hayes,et al.  The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. , 1995, Critical reviews in biochemistry and molecular biology.

[34]  S. Egyházi,et al.  Contribution of glutathione transferase M3-3 to 1,3-bis(2-chloroethyl)-1-nitrosourea resistance in a human non-small cell lung cancer cell line. , 1993, Cancer research.

[35]  D. Nelson,et al.  Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. , 1993, Journal of the National Cancer Institute.

[36]  B. Ketterer,et al.  Theta, a new class of glutathione transferases purified from rat and man. , 1991, The Biochemical journal.

[37]  F. Ali-Osman,et al.  Glutathione content and glutathione-S-transferase expression in 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant human malignant astrocytoma cell lines. , 1990, Cancer research.

[38]  B. Mannervik,et al.  Glutathione transferases--structure and catalytic activity. , 1988, CRC critical reviews in biochemistry.

[39]  W. Shapiro.  Therapy of adult malignant brain tumors: what have the clinical trials taught us? , 1986, Seminars in oncology.

[40]  P. Board.  Biochemical genetics of glutathione-S-transferase in man. , 1981, American journal of human genetics.